Trikafta (elexacaftor/tezacaftor/ivacaftor) - Vertex
Effectiveness of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis carrying non-F508del variants in Brazil. (PubMed, Respir Res Clin Pract) - Sep 25, 2026 - No abstract available 
Journal • Cystic Fibrosis • Genetic Disorders • Immunology • Pulmonary Disease • Respiratory Diseases
http://www.ncbi.nlm.nih.gov/pubmed/42781397
 
Bruna Ziegler; Caroline Souza Sokoloski; Débora Carla Chong E Silva; Leonardo Araújo Pinto; Luiz Vicente Ribeiro Ferreira da Silva; Mariane Gonçalves Martynychen Canan; Paulo de Tarso Roth Dalcin; Raphael Freitas Jaber De Oliveira; Rodrigo Abensur Athanazio; Samia Zahi Rached
 
Sep 25, 2026
 
Prev Next